394 related articles for article (PubMed ID: 20214966)
1. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes.
Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M
Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966
[TBL] [Abstract][Full Text] [Related]
2. Adsorption of lipid liquid crystalline nanoparticles: effects of particle composition, internal structure, and phase behavior.
Chang DP; Jankunec M; Barauskas J; Tiberg F; Nylander T
Langmuir; 2012 Jul; 28(29):10688-96. PubMed ID: 22725977
[TBL] [Abstract][Full Text] [Related]
3. Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces.
Chang DP; Jankunec M; Barauskas J; Tiberg F; Nylander T
ACS Appl Mater Interfaces; 2012 May; 4(5):2643-51. PubMed ID: 22515950
[TBL] [Abstract][Full Text] [Related]
4. Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase.
Wadsäter M; Barauskas J; Nylander T; Tiberg F
ACS Appl Mater Interfaces; 2014 May; 6(10):7063-9. PubMed ID: 24779728
[TBL] [Abstract][Full Text] [Related]
5. Structural effects of the dispersing agent polysorbate 80 on liquid crystalline nanoparticles of soy phosphatidylcholine and glycerol dioleate.
Wadsäter M; Barauskas J; Rogers S; Skoda MW; Thomas RK; Tiberg F; Nylander T
Soft Matter; 2015 Feb; 11(6):1140-50. PubMed ID: 25531822
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
[TBL] [Abstract][Full Text] [Related]
7. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
8. "Sponge" nanoparticle dispersions in aqueous mixtures of diglycerol monooleate, glycerol dioleate, and polysorbate 80.
Barauskas J; Misiunas A; Gunnarsson T; Tiberg F; Johnsson M
Langmuir; 2006 Jul; 22(14):6328-34. PubMed ID: 16800694
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the study of lipid-based cubic liquid crystalline nanoparticles as drug delivery system].
Wu HB; Huo DF; Jiang XG
Yao Xue Xue Bao; 2008 May; 43(5):450-5. PubMed ID: 18717329
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption.
Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L
Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of quercetin-loaded lipid liquid crystalline systems.
Linkevičiūtė A; Misiūnas A; Naujalis E; Barauskas J
Colloids Surf B Biointerfaces; 2015 Apr; 128():296-303. PubMed ID: 25701115
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
14. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide.
Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M
J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194
[TBL] [Abstract][Full Text] [Related]
15. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
16. Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior.
Sagnella SM; Conn CE; Krodkiewska I; Moghaddam M; Drummond CJ
J Phys Chem B; 2010 Feb; 114(4):1729-37. PubMed ID: 20063872
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
Elgindy NA; Mehanna MM; Mohyeldin SM
Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
[TBL] [Abstract][Full Text] [Related]
19. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
20. The lipolytic degradation of highly structured cubic micellar nanoparticles of soy phosphatidylcholine and glycerol dioleate by phospholipase A
Wadsäter M; Barauskas J; Tiberg F; Nylander T
Chem Phys Lipids; 2018 Mar; 211():86-92. PubMed ID: 29132829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
